Bechtold Andrea G, Scheuer Deborah A
Division of Pharmacology, University of Missouri-Kansas City, Kansas City, Missouri 64108, USA.
Am J Physiol Regul Integr Comp Physiol. 2006 Apr;290(4):R1003-11. doi: 10.1152/ajpregu.00345.2005. Epub 2005 Nov 3.
Systemic corticosterone (Cort) modulates arterial baroreflex control of both heart rate and renal sympathetic nerve activity. Because baroreceptor afferents terminate in the dorsal hindbrain (DHB), an area with dense corticosteroid receptor expression, we tested the hypothesis that prolonged activation of DHB Cort receptors increases the midpoint and reduces the gain of arterial baroreflex control of heart rate in conscious rats. Small (3-4 mg) pellets of Cort (DHB Cort) or Silastic (DHB Sham) were placed on the surface of the DHB, or Cort was administered systemically by placing a Cort pellet on the surface of the dura (Dura Cort). Baroreflex control of heart rate was determined in conscious male Sprague Dawley rats on each of 4 days after initiation of treatment. Plots of arterial pressure vs. heart rate were analyzed using a four-parameter logistic function. After 3 days of treatment, the arterial pressure midpoint for baroreflex control of heart rate was increased in DHB Cort rats (123 +/- 2 mmHg) relative to both DHB Sham (108 +/- 3 mmHg) and Dura Cort rats (109 +/- 2 mmHg, P < 0.05). On day 4, baseline arterial pressure was greater in DHB Cort (112 +/- 2 mmHg) compared with DHB Sham (105 +/- 2 mmHg) and Dura Cort animals (106 +/- 2 mmHg, P < 0.05), and the arterial pressure midpoint was significantly greater than mean arterial pressure in the DHB Cort group only. Also on day 4, maximum baroreflex gain was reduced in DHB Cort (2.72 +/- 0.12 beats x min(-1) x mmHg(-1)) relative to DHB Sham and Dura Cort rats (3.51 +/- 0.28 and 3.37 +/- 0.27 beats x min(-1) x mmHg(-1), P < 0.05). We conclude that Cort acts in the DHB to increase the midpoint and reduce the gain of the heart rate baroreflex function.
全身性皮质酮(Cort)可调节动脉压力反射对心率和肾交感神经活动的控制。由于压力感受器传入神经在延髓后区(DHB)终止,该区域有密集的皮质类固醇受体表达,我们检验了以下假设:在清醒大鼠中,DHB皮质酮受体的长期激活会提高动脉压力反射对心率控制的中点并降低其增益。将小的(3 - 4毫克)皮质酮(DHB Cort)或硅橡胶(DHB假手术组)微丸置于DHB表面,或者通过将皮质酮微丸置于硬脑膜表面(硬脑膜皮质酮组)进行全身性给予皮质酮。在开始治疗后的4天里,每天对清醒雄性Sprague Dawley大鼠的心率压力反射控制进行测定。使用四参数逻辑函数分析动脉压与心率的关系图。治疗3天后,与DHB假手术组(108±3 mmHg)和硬脑膜皮质酮组(109±2 mmHg,P<0.05)相比,DHB皮质酮组大鼠中动脉压力反射控制心率的中点升高(123±2 mmHg)。在第4天,与DHB假手术组(105±2 mmHg)和硬脑膜皮质酮组动物(106±2 mmHg,P<0.05)相比,DHB皮质酮组的基线动脉压更高(112±2 mmHg),并且仅在DHB皮质酮组中动脉压力反射中点显著高于平均动脉压。同样在第4天,与DHB假手术组和硬脑膜皮质酮组大鼠(分别为3.51±0.28和3.37±0.27次·分钟⁻¹·mmHg⁻¹)相比,DHB皮质酮组的最大压力反射增益降低(2.72±0.12次·分钟⁻¹·mmHg⁻¹,P<0.05)。我们得出结论,皮质酮在DHB起作用,提高心率压力反射功能的中点并降低其增益。